ENTA Operating Cash Flow Growth
Enanta Pharmaceuticals Inc · Operating Cash Flow Growth
ENTA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-156.96%period ending
ENTA Quarterly Cash from Operations YoY % (53.24% → -156.96%)
Year-over-year change
High-resolution chart · PNG
ENTA operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -156.9633% | |
| 46.9454% | |
| 30.3672% | |
| 37.6058% | |
| 218.4839% | |
| 52.8408% | |
| 32.7637% | |
| 51.8563% | |
| 54.0121% | |
| -107.5093% | |
| 29.8897% | |
| -39.0627% | |
| -8.5332% | |
| 47.7422% | |
| -168.563% | |
| 26.1025% | |
| -0.3254% | |
| -475.9991% | |
| 10.8731% | |
| -35.9615% | |
| -557.4421% | |
| -131.2049% | |
| -220.44% | |
| -280.9362% | |
| -277.1812% | |
| -51.2265% | |
| -59.136% | |
| -69.8493% | |
| -37.4259% | |
| 497.0177% | |
| 586.1873% | |
| -50.5444% | |
| 184.4037% | |
| -152.4317% | |
| 40.1908% | |
| 2,795.4845% | |
| -127.0833% | |
| -129.8588% | |
| -89.5142% | |
| 10.4842% | |
| 85.1299% | |
| -89.8302% | |
| 634.6346% | |
| 51.8451% | |
| -140.4506% | |
| 2,493.7288% | |
| 4.4456% | |
| -97.0435% | |
| 692.9078% | |
| -141.1642% | |
| -164.9088% | |
| -47.0623% | |
| -54.7022% | |
| -67.9876% | |
| 383.7202% | |
| 53.2418% |